Trial Details
RECRUITINGBasic Information
| Clinical ID | c370 |
|---|---|
| Identifier | NCT06699121 |
| Trial Title | A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Primary Sclerosing Cholangitis (PSC) |
| Interventions | DRUG: LB-P8 low-dose|DRUG: LB-P8 high-dose|DRUG: Placebo |
Participant Information
| Sponsor | LISCure Biosciences |
|---|---|
| City | Sacramento |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-11 |
|---|---|
| Primary Completion Date | 2028-03 |
| Completion Date | 2029-02 |